共 4 条
- [3] Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate -: A two-year randomized trial ARTHRITIS AND RHEUMATISM, 2005, 52 (11): : 3360 - 3370
- [4] Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (04) : 508 - 513